2024 HCPCS Code Q2040
Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
TAGS: viable preparation leukapheresis million infusion
| Notice | HCPCS Q2040 terminated on December 31, 2018. |
| Short Description | Tisagenlecleucel car-pos t |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2019 |
| HCPCS Code Added Date | January 01, 2018 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4276 - Orion, per sq cm
- Q4277 - Woundplus e-grat, per sq cm
- Q4278 - Epieffect, per sq cm
- Q4279 - Vendaje ac, per sq cm
- Q4280 - Xcell amnio matrix per sq cm
- Q4281 - Barrera slor dl per sq cm
- Q4282 - Cygnus dual per sq cm
- Q4283 - Biovance tri or 3l, sq cm
- Q4284 - Dermabind sl, per sq cm
- Q4285 - Nudyn dl or dl mesh pr sq cm
- Q4286 - Nudyn sl or slw, per sq cm
- Q4287 - Dermabind dl, per sq cm
- Q4288 - Dermabind ch, per sq cm
- Q4289 - Revoshield+ amnio, per sq cm
- Q4290 - Membrane wrap hydr per sq cm
- Q4291 - Lamellas xt, per sq cm
- Q4292 - Lamellas, per sq cm
- Q4293 - Acesso dl, per sq cm
- Q4294 - Amnio quad-core, per sq cm
- Q4295 - Amnio tri-core, per sq cm